Abstract
For new chemical entities, assessing a compound's abuse potential is an important component of the drug development process. To ensure regulators make the correct evaluation of a compound's abuse liability, it is vital for pharmaceutical companies to understand the appropriate preapproval measures for assessing a new chemical entity's abuse potential and the required registration procedures for making the recommendation. The goal of this review is to present an overview of the scheduling process as it relates to drug development and marketing registration.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
